No Data
No Data
No Data
No Data
No Data
Press Release: Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 07, 2024-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company commi
Dow JonesMay 7 19:22
Syros to Participate in Upcoming Investor Conferences
Download as PDF May 07, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treat
Syros PharmaceuticalsMay 7 12:00
Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
Download as PDF May 07, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treat
Syros PharmaceuticalsMay 7 12:00
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
Yahoo FinanceApr 10 21:49
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading
Health care stocks were mixed late Tuesday afternoon with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.1%. The iShares Biotechnology ETF (IBB) climbe
MT NewswiresApr 10 03:53
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also f
BenzingaApr 10 02:34
No Data
No Data